Regulation of immune responses by L-arginine metabolism, Nature Reviews Immunology, vol.174, issue.8, pp.641-54, 2005. ,
DOI : 10.1128/IAI.72.5.2723-2730.2004
Tumor-induced tolerance and immune suppression by myeloid derived suppressor cells, Immunological Reviews, vol.176, issue.1, pp.162-79, 2008. ,
DOI : 10.1158/0008-5472.CAN-06-4639
Immunosuppressive Strategies that are Mediated by Tumor Cells, Annual Review of Immunology, vol.25, issue.1, pp.267-96, 2007. ,
DOI : 10.1146/annurev.immunol.25.022106.141609
Abe J Chemokine-mediated rapid turnover of myeloid-derived suppressor cells in tumor-bearing mice ,
The role of tumour-associated macrophages in tumour progression: implications for new anticancer therapies, The Journal of Pathology, vol.7, issue.3, pp.254-65, 2002. ,
DOI : 10.1002/path.1027
High Numbers of Tumor-Associated Macrophages Have an Adverse Prognostic Value That Can Be Circumvented by Rituximab in Patients With Follicular Lymphoma Enrolled Onto the GELA-GOELAMS FL-2000 Trial, Journal of Clinical Oncology, vol.26, issue.3, pp.440-446, 2008. ,
DOI : 10.1200/JCO.2007.12.8298
Distinct Role of Macrophages in Different Tumor Microenvironments, Cancer Research, vol.66, issue.2, pp.605-617, 2006. ,
DOI : 10.1158/0008-5472.CAN-05-4005
Identification of discrete tumor-induced myeloid-derived suppressor cell subpopulations with distinct T cell-suppressive activity, Blood, vol.111, issue.8, pp.4233-4277, 2008. ,
DOI : 10.1182/blood-2007-07-099226
Evidence for a tumoral immune resistance mechanism based on tryptophan degradation by indoleamine 2,3-dioxygenase, Nature Medicine, vol.9, issue.10, pp.1269-74, 2003. ,
DOI : 10.1038/nm934
Novel Tryptophan Catabolic Enzyme IDO2 Is the Preferred Biochemical Target of the Antitumor Indoleamine 2,3-Dioxygenase Inhibitory Compound D-1-Methyl-Tryptophan, Cancer Research, vol.67, issue.15, pp.7082-7089, 2007. ,
DOI : 10.1158/0008-5472.CAN-07-1872
Proteomics analysis of Hodgkin lymphoma: identification of new players involved in the cross-talk between HRS cells and infiltrating lymphocytes, Blood, vol.111, issue.4, pp.2339-2385, 2008. ,
DOI : 10.1182/blood-2007-09-112128
Zacharewski TR Comparative temporal and dose-dependent morphological and transcriptional uterine effects elicited by tamoxifen and ethynylestradiol in immature, ovariectomized mice, BMC Genomics, vol.8, 2007. ,
Immunosuppressive regulatory T cells are abundant in the reactive lymphocytes of Hodgkin lymphoma, Blood, vol.103, issue.5, pp.1755-62, 2004. ,
DOI : 10.1182/blood-2003-07-2594
The MAL gene is expressed in primary mediastinal large B-cell lymphoma, Blood, vol.94, issue.10, pp.3567-75, 1999. ,
Cutting Edge: STAT6 Serves as a Positive and Negative Regulator of Gene Expression in IL-4-Stimulated B Lymphocytes, The Journal of Immunology, vol.168, issue.3, pp.996-1000, 2002. ,
DOI : 10.4049/jimmunol.168.3.996
Signal transducer and activator of transcription 6 is frequently activated in Hodgkin and Reed-Sternberg cells of Hodgkin lymphoma, Blood, vol.99, issue.2, pp.618-644, 2002. ,
DOI : 10.1182/blood.V99.2.618
IL-4 protein expression and basal activation of Erk in vivo in follicular lymphoma, Blood, vol.112, issue.9, pp.3818-3844, 2008. ,
DOI : 10.1182/blood-2008-02-138933
Molecular Diagnosis of Primary Mediastinal B Cell Lymphoma Identifies a Clinically Favorable Subgroup of Diffuse Large B Cell Lymphoma Related to Hodgkin Lymphoma, The Journal of Experimental Medicine, vol.81, issue.6, pp.851-62, 2003. ,
DOI : 10.1084/jem.20022089
Selection Assay Using a Myc-Induced B-Cell Tumor, Annals of the New York Academy of Sciences, vol.59, issue.1, pp.145-59, 2005. ,
DOI : 10.1196/annals.1339.047
Use of IGHV3-21 in chronic lymphocytic leukemia is associated with high-risk disease and reflects antigen-driven, post-germinal center leukemogenic selection, Blood, vol.111, issue.10, pp.5101-5109, 2008. ,
DOI : 10.1182/blood-2007-12-130229
Stromal gene expression predicts clinical outcome in breast cancer, Nature Medicine, vol.25, issue.5, pp.518-545, 2008. ,
DOI : 10.1038/nm1764
Pathophysiological aspects of memory B-cell development, Trends in Immunology, vol.29, issue.1, pp.25-33, 2008. ,
DOI : 10.1016/j.it.2007.10.005
URL : https://hal.archives-ouvertes.fr/hal-00294276